<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Skin preparations: corticosteroids; Corticosteroids: skin: eczema; Adrenal: suppression: topical corticosteroids; Insect stings; Angular cheilitis: inflammation; Cheilitis, angular: inflammation; Corticosteroids: skin: psoriasis; Psoriasis: corticosteroids; Fingertip unit; FTU see Fingertip unit; Corticosteroids: skin: suitable quantities" /><meta name="IX" content="Skin preparations: corticosteroids; Corticosteroids: skin: eczema; Adrenal: suppression: topical corticosteroids; Insect stings; Angular cheilitis: inflammation; Cheilitis, angular: inflammation; Corticosteroids: skin: psoriasis; Psoriasis: corticosteroids; Fingertip unit; Corticosteroids: skin: suitable quantities" /><meta name="IXN" content="FTU see Fingertip unit" /><title>13.4 Topical corticosteroids: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../383/theme.css" /><link type="text/css" rel="stylesheet" href="204/style.css" /><link type="image/x-icon" rel="shortcut icon" href="../../favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP7564-topical-corticosteroids.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8/jquery.min.js"></script><script type="text/javascript" src="../../383/scripts.js"></script><style type="text/css">
          .contentsbox { position: fixed; z-index:1001; }
          .contentsbox_wrap { overflow: hidden; width: 20px; height: 130px; position: absolute; left: 0; top: 0; }
        </style><!--[if IE 8]>
          <style type="text/css">
          #p1 {
          float: left;
          padding-bottom: 15em;
          }
          </style>
          <![endif]--><!--[if lte IE 8]>
          <style type="text/css">
          #start-search input {
          height: 28px;
          padding-top: 8px;
          }
          @media screen {
          #pV {
          display: block !important;
          }
          }
          </style>
          <![endif]--><!--[if IE 7]>
          <style type="text/css">
          #start-search input {
          position: absolute !important;
          left: 0;
          top: 0;
          }
          .as-shadow {
          margin-left: -4px !important;
          color: silver;
          }
          </style>
          <![endif]--><!--[if lte IE 7]>
          <style type="text/css">
          .menu {
          height: 1%;
          }
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }

          #account-info ul li a {
          width: 12em;
          }
          #opts ul li span {
          width: 12em;
          }
          div.as-select ul li ul li span {
          width: 40em;
          }
          div.menu ul li ul li {
          float: left !important;
          }
          #pQ fieldset, #qd, #input-box, #pub-list, #start-search, #end-search {
          display: inline;
          float: left;
          height: 100%;
          padding: 0;
          margin: 0;
          position: relative;
          }
          #hM a, #hM a img {
          border: none;
          display: inline-block;
          float: left;
          }
          #qd input {
          float: left;
          display: inline-block !important;
          }
          #start-search input {
          height: 28px;
          padding-top: 8px !important;
          }
          #end-search, #end-search input {
          height: 36px !important;
          }
          #hM, #content, #searchForm, #purple-menu {
          width: expression(document.body.clientWidth > 63 * parseInt(document.body.currentStyle.fontSize) ? '63em': 'auto');
          margin: 0 auto;
          }
          #pQ {
          z-index: 1;
          }
          </style>
          <![endif]--><!--[if lte IE 6]>
          <style type="text/css">
          body {
          height: 100%;
          }
          div.menu ul li a, div.menu ul li span {
          display: inline-block;
          }
          div.menu ul li ul li {
          clear: both;
          }
          div.as-select ul li span {
          height: 20px;
          padding-top: 16px;
          padding-left: 1em;
          padding-bottom: 0;
          padding-left: 1em;
          margin: 4px 0;
          border-right: 1px solid #888;
          background-image: url("images/dropdown_img.png");
          background-repeat: repeat-x;
          overflow-x: hidden;
          }
          div.as-select ul li ul li span {
          font: bold 10px Verdana !important;
          padding: 4px 1em !important;
          color: #2D2D2D;
          background: white;
          text-decoration: none !important;
          white-space: nowrap;
          border: none !important;
          float: left;
          }
          div.menu span.hover {
          background: #8F1F8D;
          color: white;
          }
          </style>
          <![endif]--></head><body><!--[if lte IE 6]>
          <script type="text/javascript">
          jQuery(document).ready(function($) {
          $('a.mclogo').html('<img src="images/mc_logo.gif" class="logo" />');
          });
          </script>
          <![endif]--><?highlighter off?><div id="hC"><div id="vH"><div id="pU"><a class="mclogo" href="http://www.medicinescomplete.com/about/"><img class="logo" src="../../images/mc_logo.png" alt="MedicinesComplete" /></a><div id="hM"><div id="vM" class="menu"><ul><li><a href="http://www.medicinescomplete.com/mc/index.htm">Home</a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm">Help</a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP7564-topical-corticosteroids.htm">Feedback</a></li><li id="account-info"><a href="http://www.medicinescomplete.com/mc/account.htm">BNF.org Free Access</a><ul><li><a href="http://www.medicinescomplete.com/mc/account.htm">My Account</a></li><li><a href="http://www.medicinescomplete.com/mc/subscribe.htm">Subscribe</a></li><li><a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li><a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul></li></ul></div><a id="pD" accesskey="s" rel="bookmark" href="PHP7564-topical-corticosteroids.htm#pB" title="Skip Navigation">Skip Navigation</a></div></div><div id="pA"><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 12 Mar 2013 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="search-in">Publication</label><label for="q">Search for</label><div id="qd"><div id="start-search"><div class="as-select menu" id="pub-list"><ul><li><span>British National Formulary</span><ul></ul></li></ul></div><div id="input-box"><input type="text" id="q" name="q" accesskey="4" /></div></div><div id="end-search"><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div></div></div><div id="pH"><div id="pN"><div id="pT"><!--[if lte IE 7]>
             
            <![endif]--><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF March 2013</a> &gt; <a href="PHP7449-skin.htm">13 Skin</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP7563-topical-antihistamines.htm" title="Previous: TOPICAL ANTIHISTAMINES">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP7580-topical-corticosteroid-preparation-potencies.htm" title="Next: Topical corticosteroid preparation potencies">Next page</a> ►</div></div></div></div><div id="content"><div id="p1"><div id="pB"><?highlighter on?><h1><span>13.4 </span>Topical corticosteroids</h1><?highlighter off?><?highlighter on?><div id="pC" class="jN"><p id="PHP7565">Topical corticosteroids are used for the treatment of inflammatory conditions of the skin (other than those arising from an infection), in particular eczema (<a title="sub-section: Preparations for eczema" href="PHP7687-preparations-for-eczema.htm">section 13.5.1</a>), contact dermatitis, <a title="target-block: Insect stings" href="PHP252-snake-bites-and-animal-stings.htm#PHP254">insect stings</a>, and eczema of scabies (<a title="monograph-family: Scabies" href="PHP8065-scabies.htm">section 13.10.4</a>). Corticosteroids suppress the inflammatory reaction during use; they are not curative and on discontinuation a rebound exacerbation of the condition may occur. They are generally used to relieve symptoms and suppress signs of the disorder when other measures such as emollients are ineffective.</p><p>Topical corticosteroids are of no value in the treatment of urticaria and they are <strong>contra-indicated</strong> in rosacea; they may worsen ulcerated or secondarily infected lesions. They should not be used indiscriminately in pruritus (where they will only benefit if inflammation is causing the itch) and are <strong>not</strong> recommended for acne vulgaris.</p><p>Systemic or very potent topical corticosteroids should be avoided or given only under specialist supervision in <em>psoriasis</em> because, although they may suppress the psoriasis in the short term, relapse or vigorous rebound occurs on withdrawal (sometimes precipitating severe pustular psoriasis). For the role of topical corticosteroids in the treatment of psoriasis, see section <a title="BNF:sub-section: Preparations for psoriasis" href="PHP7698-preparations-for-psoriasis.htm">13.5.2</a>.</p><p>In general, the most potent topical corticosteroids should be reserved for recalcitrant dermatoses such as <em>chronic discoid lupus erythematosus</em>, <em>lichen simplex chronicus</em>, <em>hypertrophic lichen planus</em>, and <em>palmoplantar pustulosis</em>. Potent corticosteroids should generally be avoided on the face and skin flexures, but specialists occasionally prescribe them for use on these areas in certain circumstances.</p><p>When topical treatment has failed, intralesional corticosteroid injections (<a title="sub-sub-section: Local corticosteroid injections" href="PHP6527-local-corticosteroid-injections.htm">section 10.1.2.2</a>) may be used. These are more effective than the very potent topical corticosteroid preparations and should be reserved for severe cases where there are localised lesions such as <em>keloid scars</em>, <em>hypertrophic lichen planus</em>, or <em>localised alopecia areata</em>.</p><div id="PHP7568"><h2>Perioral lesions</h2><p><strong>Hydrocortisone</strong> cream 1% can be used for up to 7 days to treat uninfected inflammatory lesions on the lips. <strong>Hydrocortisone and miconazole</strong> cream or ointment is useful where infection by susceptible organisms and inflammation co-exist, particularly for initial treatment (up to 7 days) e.g. in angular cheilitis (see also <a title="target-block: Angular cheilitis" href="PHP7381-oropharyngeal-fungal-infections.htm#PHP7382">section 12.3.2</a>). Organisms susceptible to miconazole include <em>Candida</em> spp. and many Gram-positive bacteria including streptococci and staphylococci. </p></div><div><h2>Children</h2><p>Children, especially infants, are particularly susceptible to side-effects. However, concern about the safety of topical corticosteroids in children should not result in the child being undertreated. The aim is to control the condition as well as possible; inadequate treatment will perpetuate the condition. A mild corticosteroid such as hydrocortisone 0.5% or 1% is useful for treating nappy rash (<a title="sub-section: Barrier preparations" href="PHP7530-barrier-preparations.htm">section 13.2.2</a>) and hydrocortisone 1% for atopic eczema in childhood (<a title="sub-section: Preparations for eczema" href="PHP7687-preparations-for-eczema.htm">section 13.5.1</a>). A moderately potent or potent corticosteroid may be appropriate for severe atopic eczema on the limbs, for 1–2 weeks only, switching to a less potent preparation as the condition improves. In an acute flare-up of atopic eczema, it may be appropriate to use more potent formulations of topical corticosteroids for a short period to regain control of the condition. A very potent corticosteroid should be initiated under the supervision of a specialist. Continuous daily application of a mild corticosteroid such as hydrocortisone 1% is equivalent to a potent corticosteroid such as betamethasone 0.1% applied intermittently. Carers of young children should be advised that treatment should <strong>not</strong> necessarily be reserved to ‘treat only the worst areas’ and they may need to be advised that patient information leaflets may contain inappropriate advice for the patient's condition.</p></div><div><h2>Choice of formulation</h2><p>Water-miscible corticosteroid <em>creams</em> are suitable for moist or weeping lesions whereas <em>ointments</em> are generally chosen for dry, lichenified or scaly lesions or where a more occlusive effect is required. <em>Lotions</em> may be useful when minimal application to a large or hair-bearing area is required or for the treatment of exudative lesions. <em>Occlusive polythene or hydrocolloid dressings</em> increase absorption, but also increase the risk of side-effects; they are therefore used only under supervision on a short-term basis for areas of very thick skin (such as the palms and soles). The inclusion of urea or salicylic acid also increases the penetration of the corticosteroid.</p><p>In the BNF topical corticosteroids for the skin are categorised as ‘mild’, ‘moderately potent’, ‘potent’ or ‘very potent’ (see <a title="monograph-family: Topical corticosteroid preparation potencies" href="PHP7580-topical-corticosteroid-preparation-potencies.htm">Topical corticosteroid preparation potencies</a>); the <strong>least potent</strong> preparation which is effective should be chosen but dilution should be avoided whenever possible.</p></div><div id="PHP7569"><h2>Cautions</h2><p>Avoid prolonged use of a topical corticosteroid on the face (and keep away from eyes). In children avoid prolonged use and use potent or very potent corticosteroids under specialist supervision; extreme caution is required in dermatoses of infancy including nappy rash—treatment should be limited to 5–7 days.</p> <div id="PHP7571" class="cF"><div class="cE"><h3 class="cT">Psoriasis</h3> <p class="cT">The use of potent or very potent corticosteroids in psoriasis can result in rebound relapse, development of generalised pustular psoriasis, and local and systemic toxicity.</p></div></div> </div><div id="PHP7572"><h2>Contra-indications</h2><p>Topical corticosteroids are contra-indicated in untreated bacterial, fungal, or viral skin lesions, in acne, in rosacea, and in perioral dermatitis; potent corticosteroids are contra-indicated in widespread plaque psoriasis (see notes above).</p> </div><div id="PHP7574"><h2>Side-effects</h2><p><em>Mild</em> and <em>moderately potent</em> topical corticosteroids are associated with few side-effects but care is required in the use of <em>potent</em> and <em>very potent</em> corticosteroids. Absorption through the skin can rarely cause adrenal suppression and even Cushing's syndrome (<a title="topic: Disadvantages of corticosteroids" href="PHP4353-side-effects-of-corticosteroids.htm">section 6.3.2</a>), depending on the area of the body being treated and the duration of treatment. Absorption is greatest where the skin is thin or raw, and from intertriginous areas; it is increased by occlusion. Local side-effects include:</p><ul><li><p>spread and worsening of untreated infection;</p> </li><li><p>thinning of the skin which may be restored over a period after stopping treatment but the original structure may never return;</p> </li><li><p>irreversible striae atrophicae and telangiectasia;</p> </li><li><p>contact dermatitis;</p> </li><li><p>perioral dermatitis;</p> </li><li><p>acne, or worsening of acne or rosacea;</p> </li><li><p>mild depigmentation which may be reversible;</p> </li><li><p>hypertrichosis also reported.</p> </li></ul><div class="cI"><p>In order to minimise the side-effects of a topical corticosteroid, it is important to apply it <strong>thinly</strong> to affected areas <strong>only</strong>, no more frequently than <strong>twice daily</strong>, and to use the least potent formulation which is fully effective.</p></div></div><div id="PHP7575"><h2>Application</h2><p>Topical corticosteroid preparations should be applied no more frequently than twice daily; once daily is often sufficient.</p><p id="PHP7576">Topical corticosteroids should be spread thinly on the skin but in sufficient quantity to cover the affected areas. The length of cream or ointment expelled from a tube may be used to specify the quantity to be applied to a given area of skin. This length can be measured in terms of a <em>fingertip unit</em> (the distance from the tip of the adult index finger to the first crease). One fingertip unit (approximately 500 mg) is sufficient to cover an area that is twice that of the flat adult palm.</p>  <div class="table" id="PHP7577"><div class="cAA"><span></span>Suitable quantities of corticosteroid preparations to be prescribed for specific areas of the body</div><table class="table" summary="Corticosteroids: skin: suitable quantitiesSuitable quantities of corticosteroid preparations to be prescribed for specific areas of the body" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;border-top: 1pt solid ; border-bottom: 1pt solid ; "><colgroup><col /><col /></colgroup><thead><tr><th style="border-bottom: 1pt solid ; "> </th><th style="border-bottom: 1pt solid ; ">Creams and Ointments</th></tr></thead><tbody><tr><td style="">Face and neck</td><td style="">15 to 30 g</td></tr><tr><td style="">Both hands</td><td style="">15 to 30 g</td></tr><tr><td style="">Scalp</td><td style="">15 to 30 g</td></tr><tr><td style="">Both arms</td><td style="">30 to 60 g</td></tr><tr><td style="">Both legs</td><td style="">100 g</td></tr><tr><td style="">Trunk</td><td style="">100 g</td></tr><tr><td style="border-bottom: 1pt solid ; ">Groins and genitalia</td><td style="border-bottom: 1pt solid ; ">15 to 30 g</td></tr><tr><td style="" colspan="2">These amounts are usually suitable for an adult for a single daily application for 2 weeks</td></tr></tbody></table></div> </div><p id="PHP7578">If a patient is using topical corticosteroids of different potencies, the patient should be told when to use each corticosteroid. The potency of each topical corticosteroid (see <a title="monograph-family: Topical corticosteroid preparation potencies" href="PHP7580-topical-corticosteroid-preparation-potencies.htm">Topical Corticosteroid Preparation Potencies</a>) should be included on the label with the directions for use. The label should be attached to the container (for example, the tube) rather than the outer packaging.</p><p>Mixing topical preparations on the skin should be avoided where possible; several minutes should elapse between application of different preparations.</p><div id="PHP7579"><h2>Compound preparations</h2><p>The advantages of including other substances (such as antibacterials or antifungals) with corticosteroids in topical preparations are uncertain, but such combinations may have a place where inflammatory skin conditions are associated with bacterial or fungal infection, such as infected eczema. In these cases the antimicrobial drug should be chosen according to the sensitivity of the infecting organism and used regularly for a short period (typically twice daily for 1 week). Longer use increases the likelihood of resistance and of sensitisation.</p><p>The keratolytic effect of salicylic acid facilitates the absorption of topical corticosteroids; however, excessive and prolonged use of topical preparations containing salicylic acid may cause salicylism.</p></div></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP7580-topical-corticosteroid-preparation-potencies.htm" title="Topical corticosteroid preparation potencies">Topical corticosteroid preparation potencies</a></li><li id="_PHP7581-hydrocortisone"><a href="PHP7581-hydrocortisone.htm" title="HYDROCORTISONE">HYDROCORTISONE</a></li><li id="_PHP7601-hydrocortisone-butyrate"><a href="PHP7601-hydrocortisone-butyrate.htm" title="HYDROCORTISONE BUTYRATE">HYDROCORTISONE BUTYRATE</a></li><li id="_PHP7612-alclometasone-dipropionate"><a href="PHP7612-alclometasone-dipropionate.htm" title="ALCLOMETASONE DIPROPIONATE">ALCLOMETASONE DIPROPIONATE</a></li><li id="_PHP7614-beclometasone-dipropionate"><a href="PHP7614-beclometasone-dipropionate.htm" title="BECLOMETASONE DIPROPIONATE">BECLOMETASONE DIPROPIONATE</a></li><li id="_PHP7618-betamethasone-esters"><a href="PHP7618-betamethasone-esters.htm" title="BETAMETHASONE ESTERS">BETAMETHASONE ESTERS</a></li><li id="_PHP7641-clobetasol-propionate"><a href="PHP7641-clobetasol-propionate.htm" title="CLOBETASOL PROPIONATE">CLOBETASOL PROPIONATE</a></li><li id="_PHP7648-clobetasone-butyrate"><a href="PHP7648-clobetasone-butyrate.htm" title="CLOBETASONE BUTYRATE">CLOBETASONE BUTYRATE</a></li><li id="_PHP7653-diflucortolone-valerate"><a href="PHP7653-diflucortolone-valerate.htm" title="DIFLUCORTOLONE VALERATE">DIFLUCORTOLONE VALERATE</a></li><li id="_PHP7656-fludroxycortide"><a href="PHP7656-fludroxycortide.htm" title="FLUDROXYCORTIDE">FLUDROXYCORTIDE</a></li><li id="_PHP7659-fluocinolone-acetonide"><a href="PHP7659-fluocinolone-acetonide.htm" title="FLUOCINOLONE ACETONIDE">FLUOCINOLONE ACETONIDE</a></li><li id="_PHP7670-fluocinonide"><a href="PHP7670-fluocinonide.htm" title="FLUOCINONIDE">FLUOCINONIDE</a></li><li id="_PHP7672-fluocortolone"><a href="PHP7672-fluocortolone.htm" title="FLUOCORTOLONE">FLUOCORTOLONE</a></li><li id="_PHP7675-fluticasone-propionate"><a href="PHP7675-fluticasone-propionate.htm" title="FLUTICASONE PROPIONATE">FLUTICASONE PROPIONATE</a></li><li id="_PHP7679-mometasone-furoate"><a href="PHP7679-mometasone-furoate.htm" title="MOMETASONE FUROATE">MOMETASONE FUROATE</a></li><li id="_PHP7681-triamcinolone-acetonide"><a href="PHP7681-triamcinolone-acetonide.htm" title="TRIAMCINOLONE ACETONIDE">TRIAMCINOLONE ACETONIDE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP7563-topical-antihistamines.htm">Previous: TOPICAL ANTIHISTAMINES</a> | <a class="top" href="PHP7564-topical-corticosteroids.htm#">Top</a> | <a accesskey="]" href="PHP7580-topical-corticosteroid-preparation-potencies.htm">Next: Topical corticosteroid preparation potencies</a> ►</div></div></div></div><div id="pF"><div id="p2"><div id="pL"><div class="p4"><h2>Keep in touch</h2><ul><li><a href="http://www.pharmpress.com/?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Pharmaceutical Press</a></li><li><a href="http://www.rpharms.com/">Royal Pharmaceutical Society</a></li><li><a href="http://www.pharmpress.com/mc-alerts.asp?utm_source=medicinescomplete&amp;utm_medium=footer&amp;utm_campaign=medicinescomplete-referral">Sign up for our eNewsletter</a></li><li><a href="http://twitter.com/#!/PharmPress/" class="p5"><img src="../../images/twitter.png" alt="Twitter logo" />Follow us on Twitter
              </a></li><li><a href="http://www.facebook.com/pages/Pharmaceutical-Press/296104187066918" class="p5"><img src="../../images/facebook.png" alt="Facebook logo" />Find us on Facebook
              </a></li></ul></div><div class="p4"><h2>Help and Support</h2><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a></li><li><a href="http://www.medicinescomplete.com/about/contact.htm">Contact Us</a></li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a></li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a></li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div><div class="p4"><h2>Provided for</h2><div id="cL"><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2013.  All rights reserved.</a></p><p><a href="http://www.medicinescomplete.com/mc/copyright.htm">MedicinesComplete © The Pharmaceutical Press 2013</a></p></div></div></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>